BiotechTube
Home/EpiVario/Shelley Berger, PhD
SB

Shelley Berger, PhD

Co-Founder

EpiVario

Therapeutic Areas

Substance Use DisordersPsychiatric DisordersPost-Traumatic Stress Disorder

EpiVario Pipeline

DrugIndicationPhase
ACSS2 Inhibitor ProgramSubstance Use Disorders (Opioid, Alcohol, Nicotine, Cocaine) and PTSDPre-clinical

Leadership Team at EpiVario

PM
Philipp Mews, PhD
Co-Founder
TK
Thomas Kim
President & CEO
View full EpiVario profile